Updated Italian cohort data continues to confirm lack of mesothelioma risk in pooled cohort of international cosmetic talc miners and millers

References

• [ACGIH] American Conference of Governmental Industrial Hygienists 2001. TLV for Talc. Cincinnati, OH: American Conference of Governmental Industrial Hygienists.
   Google Scholar
• [ACGIH] American Conference of Governmental Industrial Hygienists 2010. TLV for Talc. Cincinnati, OH: American Conference of Governmental Industrial Hygienists.
   Google Scholar
• Addison J, Langer AM. 2000. Draft Comments on the NTP Draft Report on Carcinogens Background Document for Talc Asbestiform and Non-Asbestiform. November 2000. Yorkshire: John Addison Consultancy.
   Google Scholar
• Addison J, McConnell EE. 2008. A review of carcinogenicity studies of asbestos and non-asbestos tremolite and other amphiboles. Regul Toxicol Pharmacol. 52(1 Suppl):S187–S199.
   PubMed Web of Science ®Google Scholar
• Anderson EL, Sheehan PJ, Kalmes RM, Griffin JR. 2017. Assessment of health risk from historical use of cosmetic talcum powder. Risk Anal. 37(5):918–929.
   PubMed Web of Science ®Google Scholar
• [ATS] American Thoracic Society 1990. Health effects of tremolite. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, June 1990. American Review of Respiratory Disease. 142(6 Pt 1):1453–1458.
   PubMedGoogle Scholar
• [ATSDR] Agency for Toxic Substances and Disease Registry 2001. Toxicological Profile for Asbestos. September 2001. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry.
   Google Scholar
• Beaumont JJ, Breslow NE. 1981. Power considerations in epidemiologic studies of vinyl chloride workers. Am J Epidemiol. 114(5):725–734.
   PubMed Web of Science ®Google Scholar
• Blount AM. 1991. Amphibole content of cosmetic and pharmaceutical talcs. Environ Health Perspect. 94:225–230.
   PubMed Web of Science ®Google Scholar
• Boffetta P, Malvezzi M, Pira E, Negri E, La Vecchia C. 2018. International analysis of Age-Specific Mortality Rates From Mesothelioma on the Basis of the International Classification of Diseases, 10th Revision. J Glob Oncol. 4:1–15.
   PubMed Web of Science ®Google Scholar
• Boundy MG, Gold K, Martin K, Jr. Burgess WA, Dement JA. 1979. Occupational exposures to non-asbestiform talc in Vermont. In: Lemen R, Dement JM, editors. Dusts and Disease. Park Forest South, IL: Pathotox Publisher Inc.; p. 356–378.
   Google Scholar
• Breslow NE, Day NE. 1987. Statistical methods in cancer research. Volume II–The design and analysis of cohort studies. IARC Sci Publ. (82):1–406.
   Google Scholar
• Brown R. 1985. Memo from QRAC (Quantitative Risk Assessment Committee) to W. Gary Flamm, Ph.D. (Director, Office of Toxicological Sciences - Food and Drug Administration), RE: Asbestos in Talc. Dated June 6, 1985.
   Google Scholar
• Burns AM, Barlow CA, Banducci AM, Unice KM, Sahmel J. 2019. Potential airborne asbestos exposure and risk associated with the historical use of cosmetic talcum powder products. Risk Anal. 39(10):2272–2294.
   PubMed Web of Science ®Google Scholar
• Caneer WT. 1973. Internal Memo from W. T. Caneer (Colorado School of Mines Research Institute) to W. H. Ashton (Colorado School of Mines Research Institute), RE: Meeting with Bowling Green State University Geological Staff. Dated June 8, 1973.
   Google Scholar
• Ciocan C, Pira E, Coggiola M, Franco N, Godono A, La Vecchia C, Negri E, Boffetta P. 2022. Mortality in the cohort of talc miners and millers from Val Chisone, Northern Italy: 74 years of follow-up. Env Res. 203:111865.
   PubMed Web of Science ®Google Scholar
• Coggiola M, Bosio D, Pira E, Piolatto PG, La Vecchia C, Negri E, Michelazzi M, Bacaloni A. 2003. An update of a mortality study of talc miners and millers in Italy. Am J Ind Med. 44(1):63–69.
   PubMed Web of Science ®Google Scholar
• [CPSC] Consumer Product Safety Commission 1988. Consumer Product Safety Commission. Briefing package of the CPSC Office of the Secretary on a Petition to Ban Play Sand with Non-Asbestiform Tremolite. Washington, D.C.: U.S. Product Safety Commission.
   Google Scholar
• Cralley LJ, Key MM, Groth DH, Lainhart WS, Ligo RM. 1968. Fibrous and mineral content of cosmetic talcum products. Am Ind Hyg Assoc J. 29(4):350–354.
   PubMed Web of Science ®Google Scholar
• [CTFA] Cosmetic, Toiletry, and Fragrance Association 1976a. CFTA Method J 4-1. Asbestiform Amphibole Minerals in Cosmetic Talc. Part I: X-Ray Diffraction Method, Part II: Optical Microscopy and Dispersion-Staining Method. Washington, D.C.: The Cosmetic, Toiletry, and Fragrance Association.
   Google Scholar
• [CTFA] Cosmetic, Toiletry, and Fragrance Association 1976b. CTFA Specification: Cosmetic Talc, revised October 7, 1976. The Cosmetic, Toiletry, and Fragrance Association.
   Google Scholar
• Delgado R, Fernandez-Gonzalez MV, Gzouly M, Molinero-Garcia A, Cervera-Mata A, Sanchez-Maranon M, Herruzo M, Martin-Garcia JM. 2020. The quality of Spanish cosmetic-pharmaceutical talcum powders. Appl Clay Sci. 193:105691.
   Web of Science ®Google Scholar
• Drechsel DA, Barlow CA, Bare JL, Jacobs NF, Henshaw JL. 2018. Historical evolution of regulatory standards for occupational and consumer exposures to industrial talc. Regul Toxicol Pharmacol. 92:251–267.
   PubMed Web of Science ®Google Scholar
• Eiermann HJ. 1973. Summary and Comments on Analyses for Asbestos in Cosmetic Talc Products. October 1, 1973.
   Google Scholar
• Eiermann HJ. 1976. Internal Memo from Heinz J. Eiermann (U.S. FDA - Director, Division of Cosmetics Technology) to Robert M. Schaffner (U.S. FDA - Associate Director for Technology), RE: Asbestos in Talc. Dated March 18, 1976.
   Google Scholar
• Emory TS, Maddox JC, Kradin RL. 2020. Malignant mesothelioma following repeated exposures to cosmetic talc: A case series of 75 patients. Am J Ind Med. 63(6):484–489.
   PubMed Web of Science ®Google Scholar
• Finley BL, Benson SM, Marsh GM. 2017. Cosmetic talc as a risk factor for pleural mesothelioma: A weight of evidence evaluation of the epidemiology. Inhal Tox. 29(4):179–185.
   PubMed Web of Science ®Google Scholar
• Fitzgerald S, Harty E, Joshi TK, Frank AL. 2019. Asbestos in commercial indian talc. Am J Ind Med. 62(5):385–392.
   PubMed Web of Science ®Google Scholar
• Fiume MM, Boyer I, Bergfeld WF, Belsito DV, Hill RA, Klaassen CD, Liebler DC, Marks JG, Jr., Shank RC, Slaga TJ, et al. 2015. Safety Assessment of Talc as Used in Cosmetics. Int J Toxicol. 34(1 Suppl):66S–129S.
   PubMedGoogle Scholar
• Fordyce TA, Leonhard MJ, Mowat FS, Moolgavkar SH. 2019. A 37-year update on mortality patterns in an expanded cohort of Vermont talc miners and millers. J Occup Environ Med. 61(11):916–923.
   PubMed Web of Science ®Google Scholar
• Fordyce TA, Leonhard MJ, Mowat FS, Moolgavkar SH. 2020. Letter to the Editor: Egilman et. al.'s misrepresentation of the Fordyce et al. (2019) Vermont talc miners and millers cohort study update. J Occup Env Med. 62(1):e19–e21.
   PubMed Web of Science ®Google Scholar
• Gamble JF, Gibbs GW. 2008. An evaluation of the risks of lung cancer and mesothelioma from exposure to amphibole cleavage fragments. Regul Toxicol Pharmacol. 52(1 Suppl):S154–S186.
   PubMed Web of Science ®Google Scholar
• Gordon RE, Fitzgerald S, Millette J. 2014. Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. Int J Occup Environ Health. 20(4):318–332.
   PubMed Web of Science ®Google Scholar
• Hildick-Smith GY. 1976. The biology of talc. Br J Ind Med. 33(4):217–229.
   PubMedGoogle Scholar
• [IARC] International Agency for Research on Cancer 1987. Talc. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans: Silica and Some Silicates. Lyon: International Agency for Research on Cancer; p. 185–224.
   Google Scholar
• [IARC] International Agency for Research on Cancer 2010. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Volume 93: Carbon Black, Titanium Dioxide, and Talc. Lyon, France: International Agency for Research on Cancer.
   Google Scholar
• Ierardi AM, Marsh GM. 2020. Absence of mesothelioma risk maintained in an expanded international cohort of cosmetic talc miners and millers. Inhal Toxicol. 32(6):257–264.
   PubMed Web of Science ®Google Scholar
• Ierardi AM, Urban A, Marsh GM. 2021. A quantitative weight of evidence assessment of Hill's guidelines for causal inference for cosmetic talc as a cause of mesothelioma. Tox Appl Pharm. 417:115461.
   PubMed Web of Science ®Google Scholar
• Ilgren EB, Sartorio C, Hoskins JA. 2017. Analysis of an authentic historical Italian cosmetic talc sample - Further evidence for the lack of cancer risk. EP. 6(2):6–33.
   Google Scholar
• Interagency Working Group on Asbestos in Consumer Products [IWGACP] 2021. White Paper: IWGACP Scientific Opinions on Testing Methods for Asbestos in Cosmetic Products Containing Talc. Dated December, 2021.
   Google Scholar
• Kennedy D. 1979. Memo from Donald Kennedy (Commission of Food and Drugs) to Sidney M. Wolfe, M.D, and Mr. Benjamin Gordon (Public Citizen) RE: Letter from Sidney M. Wolfe and Mr. Benjamin Gordon Dated August 4, 1978, Discussing Talc Carcinogenesis (With Attachments). Dated January 11, 1979.
   Google Scholar
• Krause JB. 1977. Mineralogical characterization of cosmetic talc products. J Toxicol Environ Health. 2(5):1223–1226.
   PubMed Web of Science ®Google Scholar
• Lee R, Van Orden D. 2015. Letter To The Editor RE, Gordon R, Fitzgerald S, Millette J. 2014. Asbestos in commercial cosmetic talcum powder as a cause of mesothelioma in women. Int J Occup Environ Health. 20(4):318–332.
   PubMed Web of Science ®Google Scholar
• Lewin SZ. 1972. Memo from Seymour Z. Lewin (Professor of Chemistry, New York University) to Dr. Alfred Weissler (Acting Director, Division of Colors and Cosmetics Technology, Office of Product Technology, Food and Drug Administration), RE: Lewin's Final Analytical Results on the Mineral Compositions of 102 Examples of Standard, Commercial Products Containing Talc (With Attachment). Dated August 3, 1972.
   Google Scholar
• Lightfoot J, Kingston GA, Pooley FD. 1972. An Examination of Italian Mine Samples and Relevant Powders. Cardiff, UK: Cardiff University.
   Google Scholar
• Marsh GM, Ierardi AM, Benson SM, Finley BL. 2019a. Occupational exposures to cosmetic talc and risk of mesothelioma: An updated pooled cohort and statistical power analysis with consideration of latency period. Inhal Tox. 31(6):213–223.
   PubMed Web of Science ®Google Scholar
• Marsh GM, Ierardi AM. 2020. Confidence interval function analysis to evaluate the risk of mesothelioma among an expanded international cohort of cosmetic talc miners and millers. Regul Toxicol Pharmacol. 115:104696.
   PubMed Web of Science ®Google Scholar
• Marsh GM, Ierardi AM, Benson SM, Finley BL. 2019b. Response to letters regarding “Occupational exposures to cosmetic talc and risk of mesothelioma: An updated pooled cohort and statistical power analysis with consideration of latency period". Inhal Toxicol. 31(11-12):387–391.
   PubMed Web of Science ®Google Scholar
• Mattenklott M. 2007. Asbestos in Talc Powders and Soapstone - The Present State. Accessed October 13, 2017: http://www.dguv.de/medien/ifa/de/pub/grl/pdf/2009_108.pdf.
   Google Scholar
• Moline J, Bevilacqua K, Alexandri M, Gordon RE. 2020. Mesothelioma associated with the use of cosmetic talc. J Occup Environ Med. 62(1):11–17.
   PubMed Web of Science ®Google Scholar
• Moolgavkar SH, Chang ET, Mezei G, Mowat FS. 2017. Chapter 3, Epidemiology of mesothelioma. In: Testa JR, editor. Asbestos and mesothelioma current cancer research. Cham, Switzerland: Springer; p. 43–72.
   Google Scholar
• Moolgavkar SH, Meza R, Turim J. 2009. Pleural and peritoneal mesotheliomas in SEER: age effects and temporal trends, 1973–2005. Cancer Causes Control. 20(6):935–944.
   PubMed Web of Science ®Google Scholar
• Mossman BT. 2008. Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassays. Regul Toxicol Pharmacol. 52(1 Suppl):S200–S203.
   PubMed Web of Science ®Google Scholar
• Mossman BT. 2018. Mechanistic in vitro studies: What they have told us about carcinogenic properties of elongated mineral particles (EMPs). Tox Appl Pharm. 361:62–67.
   PubMed Web of Science ®Google Scholar
• [OSHA] Occupational Safety and Health Administration. 1992. 29 CFR Parts 1910 and 1926: Occupational Exposure to Asbestos, Tremolite, Anthophyllite and Actinolite; Final Rule. Fed. Reg. 57(110):24310–24331. June 8, 1992.
   Google Scholar
• Paoletti L, Caiazza S, Donelli G, Pocchiari F. 1984. Evaluation by electron microscopy techniques of asbestos contamination in industrial, cosmetic, and pharmaceutical talcs. Regul Toxicol Pharmacol. 4(3):222–235.
   PubMedGoogle Scholar
• Parkes WR. 1982. Occupational Lung Disorders. 2nd ed. Boston: Butterworths.
   Google Scholar
• Pierce JS, Riordan AS, Miller EW, Gaffney SH, Hollins DM. 2017. Evaluation of the presence of asbestos in cosmetic talcum products. Inhal Toxicol. 29(10):443–456.
   PubMed Web of Science ®Google Scholar
• Pira E, Coggiola M, Ciocan C, Romano C, La Vecchia C, Pelucchi C, Boffetta P. 2017. Mortality of talc miners and millers from Val Chisone, Northern Italy: An updated cohort study. J Occup Environ Med. 59(7):659–664.
   PubMed Web of Science ®Google Scholar
• Pooley FD. 1972. Report of the Examination of Rock Samples from the Vermont Mine. UK: Department of Mineral Exploitation, Cardiff University.
   Google Scholar
• Pooley FD. 1976. Letter from Dr. F.D. Pooley, Department of Mineral Exploitation, University College, Cardiff, to Dr. R.E. Shapiro, Ph.D., Epidemiology Unit, HFF-108, Department of Health, Education & Welfare, Public Health Service, Food and Drug Administration, Washington, D.C. Dated March 9, 1976. Cardiff: University College.
   Google Scholar
• Rohl AN, Langer AM. 1974. Identification and quantitation of asbestos in talc. Environ Health Perspect. 9:95–109.
   PubMedGoogle Scholar
• Rohl AN, Langer AM. 1979. Fibrous mineral content of consumer talc-containing products. In: Lemen R, Dement JM, editors. Dusts and Disease. Park Forest South, IL: Pathotox Publishers; p. 393–403.
   Google Scholar
• Rohl AN, Langer AM, Selikoff IJ, Tordini A, Klimentidis R, Bowes DR, Skinner DL. 1976. Consumer talcums and powders: mineral and chemical characterization. J Toxicol Environ Health. 2(2):255–284.
   PubMed Web of Science ®Google Scholar
• Rubino GF, Scansetti G, Piolatto G. 1979. Mortality and morbidity among talc miners and millers in Italy. In: Lemen R, Dement JM, editors. Dusts and Disease: Proceedings of the Conference on Occupational Exposures to Fibrous and Particulate Dust and Their Extension into the Environment. Park Forest South, IL: Pathotox Publishers; p. 357–363.
   Google Scholar
• Rubino GF, Scansetti G, Piolatto G, Romano CA. 1976. Mortality study of talc miners and millers. J Occup Med. 18:186–193.
   Google Scholar
• Selevan SG, Dement JM, Wagoner JK, Froines JR. 1979. Mortality patterns among miners and millers of non-asbestiform talc: preliminary report. J Environ Pathol Toxicol. 2(5):273–284.
   PubMedGoogle Scholar
• Snider DW, Pfeiffer DE, Mancuso JJ. 1972. Asbestosform impurities in commerical talcum powders. Compass of Sigma Gamma Epsilon. 49:65–67.
   Google Scholar
• Stoiber T, Fitzgerald S, Leiba NS. 2020. Asbestos contamination in talc-based cosmetics: An invisible cancer risk. Environ Health Insights. 14:117863022097655. 1178630220976558.
   Web of Science ®Google Scholar
• Strohmeier BR, Huntington JC, Bunker KL, Sanchez MS, Allison K, Lee RJ. 2010. What is asbestos and why is it important? Challenges of defining and characterizing asbestos. Int Geol Rev. 52(7-8):801–872.
   Web of Science ®Google Scholar
• Swanson JW. 1986. Memo from J.W. Swanson (Acting Associate Commissioner for Regulatory Affairs - U.S. Food and Drug Administration) to Mr. Phillippe Douillet, RE: Docket Number 1982P-404, Denying a November 8, 1983, Petition Requesting that Cosmetic Talc be Labeled with an Asbestos Warning Statement (Includes Enclosures/Talc Documents). Dated July 11, 1986.
   Google Scholar
• U.S. Food and Drug Administration [USFDA] 1971. FDA Meeting Minutes-Asbestos in Cosmetic Talc. August 3, 1971 - Washington, D.C.
   Google Scholar
• U.S. Food and Drug Administration [USFDA] 2021. Talc. Retrieved Jan. 31, 2022 from: https://www.fda.gov/cosmetics/cosmetic-ingredients/talc. Silver Spring, MD: U.S. Food and Drug Administration (USFDA).
   Google Scholar
• U.S. Pharmacopeia [USP] 2007. US Monographs: Talc. Retrieved Nov. 24, 2020 from: http://ftp.uspbpep.com/v29240/usp29nf24s0_m80360.html#. Rockville, MD: U.S. Pharmacopeia.
   Google Scholar
• U.S. Pharmacopeia [USP] 2020. FAQs: Modernization of the USP Talc Monograph. Retrieved Nov. 24, 2020 from: https://www.usp.org/frequently-asked-questions/talc-monograph. Rockville, MD: U.S. Pharmacopeia.
   Google Scholar
• Wegman DH, Peters JM, Boundy MG, Smith TJ. 1982. Evaluation of respiratory effects in miners and millers exposed to talc free of asbestos and silica. Br J Ind Med. 39(3):233–238.
   PubMedGoogle Scholar
• Weissler A. 1973. Internal Memo from Alfred Weissler Ph.D. (Acting Director- Division of Color Technology, U.S. Food and Drug Administration) to Dr. Robert M. Schaffner (Director - Office of Technology, U.S. Food and Drug Administration), RE: Summary and Comments on Prof. Lewin's Analytical Results for Asbestos in Talc (Enclosures Included - Final Report: X-Ray Powder Diffraction Analyses of Commerical Cosmetic Powders). Dated July 31, 1973.
   Google Scholar
• Wergeland E, Andersen A, Berheim A. 1990. Morbidity and mortality in talc-exposed workers. Am J Ind Med. 17(4):505–513.
   PubMed Web of Science ®Google Scholar
• Wergeland E, Gjertsen F, Vos L, Grimsrud TK. 2017. Cause-specific mortality and cancer morbidity in 390 male workers exposed to high purity talc, a six-decade follow-up. Am J Ind Med. 60(9):821–830.
   PubMed Web of Science ®Google Scholar
• Wild P, Leodolter K, Refregier M, Schmidt H, Zidek T, Haidinger G. 2002. A cohort mortality and nested case-control study of French and Austrian talc workers. Occup Environ Med. 59(2):98–105.
   PubMed Web of Science ®Google Scholar
• Williams C, Dell L, Adams R, Rose T, Van Orden D. 2013. State-of-the-science assessment of non-asbestos amphibole exposure: Is there a cancer risk? Environ Geochem Health. 35(3):357–377.
   PubMed Web of Science ®Google Scholar
• Zazenski R, Ashton WH, Briggs D, Chudkowski M, Kelse JW, MacEachern L, McCarthy EF, Nordhauser MA, Roddy MT, Teetsel NM. 1995. Talc: Occurrence, characterization, and consumer applications. Regul Toxicol Pharmacol. 21(2):218–229.
   PubMed Web of Science ®Google Scholar
• Zoltai T. 1979. Asbestiform and acicular mineral fragments. Ann NY Acad Sci. 330(1 Health Hazard):621–643.
   Google Scholar